Avalo Therapeutics (AVTX) Return on Capital Employed Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -494.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -649.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4,853.00 |
| 10 | Avalo Therapeutics | 317.29 Mn | 317.29 Mn | - | 13,766.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13,766.00 |
| Dec 31, 2025 | 22,390.00 |
| Sep 30, 2025 | 23,028.00 |
| Jun 30, 2025 | 16,313.00 |
| Mar 31, 2025 | 9,993.00 |
| Dec 31, 2024 | 6,273.00 |
| Sep 30, 2024 | -1,452.00 |
| Jun 30, 2024 | -9,002.00 |
| Mar 31, 2024 | 30,065.00 |
| Dec 31, 2023 | 6,764.00 |
| Sep 30, 2023 | -693.00 |
| Jun 30, 2023 | -14,289.00 |
| Mar 31, 2023 | -4,796.00 |
| Dec 31, 2022 | -24,474.00 |
| Sep 30, 2022 | -25,760.00 |
| Jun 30, 2022 | -14,297.00 |
| Mar 31, 2022 | -5,375.00 |
| Dec 31, 2021 | -3,815.00 |
| Sep 30, 2021 | -3,715.00 |
| Jun 30, 2021 | -20,195.00 |
| Mar 31, 2021 | -29,547.00 |
| Dec 31, 2020 | -25,786.00 |
| Sep 30, 2020 | -26,539.00 |
| Jun 30, 2020 | 23,723.00 |
| Mar 31, 2020 | 50,442.00 |
| Dec 31, 2019 | 43,123.00 |
| Sep 30, 2019 | 43,644.00 |
| Jun 30, 2019 | 9,721.00 |
| Mar 31, 2019 | 2,019.00 |
| Dec 31, 2018 | 6,008.00 |